Premium Research
By Sean Brodrick On November 3, 202209:42 AM Eastern
Fed Chairman Jerome Powell hammered the market yesterday, and there’s more pain to come.
Strategic Options
Subscription
By Jon D. Markman On November 3, 202206:30 AM Eastern
The medical world is on the precipice of the biggest innovation cycle in decades. This is what it means for investors.
By Chris Graebe On November 2, 202204:22 PM Eastern
It’s almost time to pull back the curtain and share this quarter’s private-deal selection.
By Jon D. Markman On November 2, 202202:30 PM Eastern
Stocks are higher Wednesday after the Federal Reserve announced its decision to lift its benchmark interest rate by 75 basis points.
Strategic Options
Subscription
By Jon D. Markman On November 2, 202206:30 AM Eastern
Volatility continued on Tuesday as the S&P 500 jumped sharply at the open, only to retreat later in the session. The benchmark S&P 500 closed at 3,856, a loss of 0.4%.
I'm not surprised bulls...
Strategic Options
Subscription
By Jon D. Markman On November 1, 202202:48 PM Eastern
Stocks have bounced off session lows on Tuesday as traders await the Fed’s monetary tightening decision.
By Mike Larson On November 1, 202208:00 AM Eastern
The Dow is on pace for its best October ever and it’s being driven by ‘old economy’ names.
Strategic Options
Subscription
By Jon D. Markman On November 1, 202206:30 AM Eastern
Bears finally caught a break on Monday as the S&P 500 closed at 3,872, a loss of 0.8%. Even with that decline, the benchmark S&P 500 advanced 8% for October, a month with a reputation for...
Strategic Options
Subscription
By Jon D. Markman On October 31, 202203:02 PM Eastern
We’ve kicked off a busy week for earnings with stocks currently falling as investors await results of the Fed’s important FOMC meeting.
By Kenny Polcari On October 31, 202212:00 PM Eastern
Today, I’m talking to Tony Sagami, editor of Disruptors & Dominators.